Literature DB >> 11684715

Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology.

M Gulyás1, A D Kaposi, G Elek, L G Szollár, A Hjerpe.   

Abstract

AIM: To determine whether assays of carcinoembryonic antigen (CEA) and cholesterol in ascites add diagnostic value to cytology.
METHODS: The additional diagnostic efficacy of the biochemical assays was studied in the ascitic fluid from 130 patients, of whom 57 had peritoneal carcinomatosis. All diagnoses were verified by subsequent necropsy and/or histology.
RESULTS: CEA concentrations over 5 ng/ml indicated carcinomas, occasionally without peritoneal involvement of the tumour. However, increased values were significantly more common in cancer with peritoneal involvement (p < 0.01), giving a sensitivity of 51% and specificity of 97% for carcinomatosis. A cholesterol value exceeding 1.21 mmol/litre was found in 93% of cancers with peritoneal involvement, but it was not entirely specific (96%) for carcinomatosis. Simultaneous increases in CEA and cholesterol concentrations were specific for carcinomatosis and this combination increased the sensitivity for diagnosing carcinomatosis from 77% with cytology alone to 88%. The correct diagnosis could thus be made in five of 12 cases with inconclusive cytology.
CONCLUSIONS: The measurements of both CEA and cholesterol concentrations in ascites give additional specific information about peritoneal carcinomatosis and can therefore be a useful adjunct to cytology-in particular, in inconclusive cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684715      PMCID: PMC1731306          DOI: 10.1136/jcp.54.11.831

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  The role of conventional cytology, immunocytochemistry, and flow cytometric DNA ploidy in the evaluation of body cavity fluids: a prospective study of 52 patients.

Authors:  L M Chen; O Lazcano; J A Katzmann; T K Kimlinger; C Y Li
Journal:  Am J Clin Pathol       Date:  1998-06       Impact factor: 2.493

2.  Isolation and characterization of a cellular protein-lipid complex from ascites fluid caused by various neoplasms.

Authors:  W H Caselmann; D Jüngst
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

3.  Tumor-associated antigens in effusions of malignant and benign origin.

Authors:  A Ammon; H Eiffert; S Reil; J H Beyer; M Droese; W Hiddemann
Journal:  Clin Investig       Date:  1993-06

4.  Care of patients with ascites.

Authors:  B A Runyon
Journal:  N Engl J Med       Date:  1994-02-03       Impact factor: 91.245

5.  Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.

Authors:  A L Gerbes; Y N Xie; J Mezger; D Jüngst
Journal:  Liver       Date:  1990-06

Review 6.  Malignancy-related ascites and ascitic fluid "humoral tests of malignancy".

Authors:  B A Runyon
Journal:  J Clin Gastroenterol       Date:  1994-03       Impact factor: 3.062

7.  Diagnostic value of ascitic fluid cholesterol levels in the prediction of malignancy.

Authors:  P B Mortensen; S D Kristensen; A Bloch; B A Jacobsen; S N Rasmussen
Journal:  Scand J Gastroenterol       Date:  1988-11       Impact factor: 2.423

8.  Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence.

Authors:  A L Gerbes; D Jüngst; Y N Xie; W Permanetter; G Paumgartner
Journal:  Cancer       Date:  1991-10-15       Impact factor: 6.860

9.  Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.

Authors:  G Castaldo; G Oriani; L Cimino; M Topa; I Mostarda; L Castellano; C Del Vecchio-Blanco; G Budillon; F Salvatore; L Sacchetti
Journal:  Clin Chem       Date:  1994-03       Impact factor: 8.327

10.  DNA analysis of malignant effusions. Comparison with cytologic diagnosis and carcinoembryonic antigen content.

Authors:  M M Pinto
Journal:  Anal Quant Cytol Histol       Date:  1992-06       Impact factor: 0.302

View more
  6 in total

1.  Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites.

Authors:  Hong Zhang; Feng Li; Qun Wei; Yu-Fei Zhu
Journal:  Med Oncol       Date:  2010-11-02       Impact factor: 3.064

2.  Peritoneal mucinous cystadenocarcinoma of probable urachal origin: a challenging diagnosis.

Authors:  D M Gore; S Bloch; W Waller; P Cohen
Journal:  J Clin Pathol       Date:  2006-10       Impact factor: 3.411

3.  Diagnostic accuracy of tumour markers in serous effusions: a validation study.

Authors:  Jaume Trapé; Rafael Molina; Francesc Sant; Jesús Montesinos; Anna Arnau; Josefina Franquesa; Rosana Blavia; Esperanza Martín; Emili Marquilles; Damià Perich; Concepción Pérez; Josep Maria Roca; Montserrat Doménech; Joan López; Josep Miquel Badal
Journal:  Tumour Biol       Date:  2012-06-08

4.  The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.

Authors:  Minkyu Jung; Hei-Cheul Jeung; Sung Sook Lee; Jun Yong Park; Soojung Hong; Soo Hyeon Lee; Sung Hoon Noh; Hyun Cheol Chung; Sun Young Rha
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-23       Impact factor: 4.553

5.  Diagnostic accuracy of ascitic cholesterol concentration for malignant ascites: a meta-analysis.

Authors:  Hong Zhu; Yongchun Shen; Kai Deng; Xia Liu; Yaqin Zhao; Taiguo Liu; Ying Huang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  1H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites.

Authors:  Lucio Zennaro; Lorenzo Nicolè; Paola Vanzani; Filippo Cappello; Ambrogio Fassina
Journal:  Pleura Peritoneum       Date:  2020-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.